SI9300542A - Benzofuran derivatives for medical use - Google Patents
Benzofuran derivatives for medical use Download PDFInfo
- Publication number
- SI9300542A SI9300542A SI9300542A SI9300542A SI9300542A SI 9300542 A SI9300542 A SI 9300542A SI 9300542 A SI9300542 A SI 9300542A SI 9300542 A SI9300542 A SI 9300542A SI 9300542 A SI9300542 A SI 9300542A
- Authority
- SI
- Slovenia
- Prior art keywords
- formula
- compound
- ethyl
- benzofuranyl
- dimethylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929221761A GB9221761D0 (en) | 1992-10-16 | 1992-10-16 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI9300542A true SI9300542A (en) | 1994-06-30 |
Family
ID=10723562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9300542A SI9300542A (en) | 1992-10-16 | 1993-10-15 | Benzofuran derivatives for medical use |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US5494910A (enExample) |
| EP (1) | EP0664804A1 (enExample) |
| JP (1) | JPH06211842A (enExample) |
| KR (1) | KR940009179A (enExample) |
| CN (1) | CN1092420A (enExample) |
| AP (1) | AP425A (enExample) |
| AU (1) | AU5333794A (enExample) |
| CA (1) | CA2146569A1 (enExample) |
| CZ (1) | CZ96895A3 (enExample) |
| EC (1) | ECSP941050A (enExample) |
| FI (1) | FI951798A0 (enExample) |
| GB (1) | GB9221761D0 (enExample) |
| HU (1) | HUT72752A (enExample) |
| IL (1) | IL107302A0 (enExample) |
| IS (1) | IS4081A (enExample) |
| MX (1) | MX9306394A (enExample) |
| NO (1) | NO951433L (enExample) |
| PE (1) | PE51294A1 (enExample) |
| PL (1) | PL308357A1 (enExample) |
| RU (1) | RU95110110A (enExample) |
| SI (1) | SI9300542A (enExample) |
| TW (1) | TW262473B (enExample) |
| WO (1) | WO1994008993A1 (enExample) |
| ZA (1) | ZA937633B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9407447D0 (en) * | 1994-04-14 | 1994-06-08 | Glaxo Group Ltd | Chemical compounds |
| US5807857A (en) * | 1994-05-19 | 1998-09-15 | Merck Sharp & Dohme Ltd. | Piperazine, piperidine and tetrahydropyridine derivative of indol-3-alkyl as 5-HT1D-α agonists |
| GB9610979D0 (en) * | 1996-05-24 | 1996-07-31 | Merck Sharp & Dohme | Therapeutic agents |
| CA2268164A1 (en) * | 1996-10-08 | 1998-04-16 | Yao-Chang Xu | New serotonin 5-ht1f agonists |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US6685951B2 (en) | 2001-07-05 | 2004-02-03 | R. T. Alamo Ventures I, Inc. | Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| US20030198669A1 (en) * | 2001-07-05 | 2003-10-23 | R.T. Alamo Ventures I, Llc | Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine |
| US20030017175A1 (en) * | 2001-07-05 | 2003-01-23 | R.T. Alamo Ventures I, Inc. | Sublingual administration of dihydroergotamine for the treatment of migraine |
| US9399053B2 (en) | 2011-07-22 | 2016-07-26 | The University Of Chicago | Treatments for migraine and related disorders |
| KR101443041B1 (ko) * | 2013-05-06 | 2014-09-23 | (주)하이레벤 | 태양광 발전설비의 효율향상설비 |
| WO2023018864A1 (en) | 2021-08-12 | 2023-02-16 | Psilosterics, Llc | Hallucinogenic and non-hallucinogenic serotonin receptor agonists and methods of making and using the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670105A1 (de) * | 1966-07-08 | 1970-12-10 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung von Benzofuryl (3)-alkylaminen und deren Salzen |
| EP0398413A1 (en) * | 1989-05-16 | 1990-11-22 | Duphar International Research B.V | "3,4-dehydropiperidine derivatives having psychotropic activity |
-
1992
- 1992-10-16 GB GB929221761A patent/GB9221761D0/en active Pending
-
1993
- 1993-10-11 IS IS4081A patent/IS4081A/is unknown
- 1993-10-14 CZ CZ95968A patent/CZ96895A3/cs unknown
- 1993-10-14 EP EP93923463A patent/EP0664804A1/en not_active Withdrawn
- 1993-10-14 AU AU53337/94A patent/AU5333794A/en not_active Abandoned
- 1993-10-14 HU HU9501073A patent/HUT72752A/hu unknown
- 1993-10-14 MX MX9306394A patent/MX9306394A/es unknown
- 1993-10-14 US US08/406,981 patent/US5494910A/en not_active Expired - Fee Related
- 1993-10-14 PL PL93308357A patent/PL308357A1/xx unknown
- 1993-10-14 RU RU95110110/04A patent/RU95110110A/ru unknown
- 1993-10-14 WO PCT/EP1993/002833 patent/WO1994008993A1/en not_active Ceased
- 1993-10-14 CA CA002146569A patent/CA2146569A1/en not_active Abandoned
- 1993-10-14 ZA ZA937633A patent/ZA937633B/xx unknown
- 1993-10-14 KR KR1019930021263A patent/KR940009179A/ko not_active Withdrawn
- 1993-10-14 FI FI951798A patent/FI951798A0/fi unknown
- 1993-10-15 JP JP5258631A patent/JPH06211842A/ja active Pending
- 1993-10-15 SI SI9300542A patent/SI9300542A/sl unknown
- 1993-10-15 AP APAP/P/1993/000581A patent/AP425A/en active
- 1993-10-15 CN CN93115016A patent/CN1092420A/zh active Pending
- 1993-10-15 IL IL107302A patent/IL107302A0/xx unknown
- 1993-11-04 TW TW082108174A patent/TW262473B/zh active
-
1994
- 1994-03-02 EC EC1994001050A patent/ECSP941050A/es unknown
- 1994-04-13 PE PE1994240029A patent/PE51294A1/es not_active Application Discontinuation
-
1995
- 1995-04-12 NO NO951433A patent/NO951433L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5494910A (en) | 1996-02-27 |
| HU9501073D0 (en) | 1995-06-28 |
| NO951433D0 (no) | 1995-04-12 |
| CA2146569A1 (en) | 1994-04-28 |
| CN1092420A (zh) | 1994-09-21 |
| FI951798A7 (fi) | 1995-04-13 |
| KR940009179A (ko) | 1994-05-20 |
| PE51294A1 (es) | 1995-01-06 |
| WO1994008993A1 (en) | 1994-04-28 |
| AP425A (en) | 1995-11-08 |
| AU5333794A (en) | 1994-05-09 |
| ECSP941050A (es) | 1994-11-16 |
| IL107302A0 (en) | 1994-01-25 |
| PL308357A1 (en) | 1995-07-24 |
| TW262473B (enExample) | 1995-11-11 |
| ZA937633B (en) | 1994-08-01 |
| JPH06211842A (ja) | 1994-08-02 |
| GB9221761D0 (en) | 1992-12-02 |
| FI951798L (fi) | 1995-04-13 |
| RU95110110A (ru) | 1996-12-27 |
| AP9300581A0 (en) | 1993-10-31 |
| NO951433L (no) | 1995-04-12 |
| HUT72752A (en) | 1996-05-28 |
| FI951798A0 (fi) | 1995-04-13 |
| MX9306394A (es) | 1994-05-31 |
| IS4081A (is) | 1994-04-17 |
| EP0664804A1 (en) | 1995-08-02 |
| CZ96895A3 (en) | 1995-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1373224B1 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| JP2941309B2 (ja) | 化合物 | |
| US4997841A (en) | Indole derivatives | |
| JP3834098B2 (ja) | ベンゾニトリル類およびベンゾフルオリド類 | |
| EP0464604B1 (en) | 1-Indolylalkyl-4-(alkoxy-pyrimidinyl)piperazines | |
| AU2002304800A1 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| AU664102B2 (en) | 4-substituted 1,2,4-triazole derivatives | |
| HU219489B (hu) | Indolszármazékok, ezeket hatóanyagként tartalmazó gyógyszerészeti készítmények és eljárás előállításukra | |
| EP0925296A1 (en) | New pharmaceutically active compounds | |
| SI9300542A (en) | Benzofuran derivatives for medical use | |
| JP5026633B2 (ja) | 細胞増殖の阻害のための置換ビスインドリルマレイミド類 | |
| PT94070A (pt) | Processo para a preparacao de derivados de piperazina | |
| JP2941333B2 (ja) | インドール誘導体 | |
| US5770611A (en) | Indole derivatives as 5HT1 -like agonists | |
| JPH0372061B2 (enExample) | ||
| JP2941702B2 (ja) | ５‐ｈｔ３レセプターにおいて５‐ｈｔの作用に拮抗するラクタム誘導体を含む医薬組成物 | |
| JPS62167761A (ja) | インド−ル誘導体 | |
| HK1026689B (en) | 5-cyclo indole compounds as 5-ht1d receptor ligands | |
| HK1026689A1 (en) | 5-cyclo indole compounds as 5-ht1d receptor ligands |